"Compositions and Methods for Treating COVID-19 and/or Acute Respiratory Failure and/or Acute Respiratory Distress Syndrome Using Tetrahydrocannabinol and Compositions Including Same" in Patent Application Approval Process (USPTO 20230263812).
In: Cannabis & Marijuana News, 2023-09-12, S. N.PAG
serialPeriodical
Zugriff:
According to other theories, other effects of the buildup of angiotensin two include cardiomyopathy (SARS-CoV-2 virus binding to cardiocyte ACE2 receptors) and stroke (SARS-CoV-2 virus binding to cerebrovascular endothelial cells ACE2 receptors). The binding, internalization, and release of the SARS-CoV-2 virus in the target cell thereby facilitate SARS-CoV-2 infection of the target cells. These other two coronaviruses are severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). [Extracted from the article]
Copyright of Cannabis & Marijuana News is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Compositions and Methods for Treating COVID-19 and/or Acute Respiratory Failure and/or Acute Respiratory Distress Syndrome Using Tetrahydrocannabinol and Compositions Including Same" in Patent Application Approval Process (USPTO 20230263812).
|
---|---|
Zeitschrift: | Cannabis & Marijuana News, 2023-09-12, S. N.PAG |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|